Your browser doesn't support javascript.
loading
A genome-wide meta-analysis of palmoplantar pustulosis implicates TH2 responses and cigarette smoking in disease pathogenesis.
Hernandez-Cordero, Ariana; Thomas, Laurent; Smail, Alice; Lim, Zhao Qin; Saklatvala, Jake R; Chung, Raymond; Curtis, Charles J; Baum, Patrick; Visvanathan, Sudha; Burden, A David; Cooper, Hywel L; Dunnill, Giles; Griffiths, Christopher E M; Levell, Nick J; Parslew, Richard; Reynolds, Nick J; Wahie, Shyamal; Warren, Richard B; Wright, Andrew; Simpson, Michael; Hveem, Kristian; Barker, Jonathan N; Dand, Nick; Løset, Mari; Smith, Catherine H; Capon, Francesca.
Afiliação
  • Hernandez-Cordero A; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, King's College London, London, United Kingdom.
  • Thomas L; Department of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; BioCore-Bioinfo
  • Smail A; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, King's College London, London, United Kingdom.
  • Lim ZQ; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, King's College London, London, United Kingdom; Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore, Singapore.
  • Saklatvala JR; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, King's College London, London, United Kingdom.
  • Chung R; NIHR BioResource Centre Maudsley, NIHR Maudsley Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust (SLaM) & Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, United Kingdom.
  • Curtis CJ; NIHR BioResource Centre Maudsley, NIHR Maudsley Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust (SLaM) & Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, United Kingdom.
  • Baum P; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
  • Visvanathan S; Boehringer Ingelheim Pharmaceuticals, Ridgefield, Conn.
  • Burden AD; School of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom.
  • Cooper HL; Portsmouth Dermatology Unit, Portsmouth Hospitals Trust, Portsmouth, United Kingdom.
  • Dunnill G; Bristol Royal Infirmary, Bristol, United Kingdom.
  • Griffiths CEM; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Department of Dermatology, King's College Hospital, King's College London, London, United Kingdom.
  • Levell NJ; Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
  • Parslew R; Department of Dermatology, Royal Liverpool Hospitals, Liverpool, United Kingdom.
  • Reynolds NJ; Institute of Cellular Medicine, Medical School, Newcastle University, Newcastle NIHR Biomedical Research Centre and the Department of Dermatology, Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Wahie S; University Hospital of North Durham, Durham, United Kingdom; Darlington Memorial Hospital, Darlington, United Kingdom.
  • Warren RB; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, United Kingdom.
  • Wright A; St Lukes Hospital, Bradford, United Kingdom; Centre for Skin Science, University of Bradford, Bradford, United Kingdom.
  • Simpson M; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, King's College London, London, United Kingdom.
  • Hveem K; HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; Department of Innovation and Research, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
  • Barker JN; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, United Kingdom.
  • Dand N; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, King's College London, London, United Kingdom.
  • Løset M; HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; Department of Dermatology, Clinic of Orthopedy, Rheumatology and Dermatology, St. Olavs Hospital, Trondheim University Hospital, Trond
  • Smith CH; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, United Kingdom.
  • Capon F; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, King's College London, London, United Kingdom. Electronic address: francesca.capon@kcl.ac.uk.
J Allergy Clin Immunol ; 154(3): 657-665.e9, 2024 Sep.
Article em En | MEDLINE | ID: mdl-38815935
ABSTRACT

BACKGROUND:

Palmoplantar pustulosis (PPP) is an inflammatory skin disorder that mostly affects smokers and manifests with painful pustular eruptions on the palms and soles. Although the disease can present with concurrent plaque psoriasis, TNF and IL-17/IL-23 inhibitors show limited efficacy. There is therefore a pressing need to uncover PPP disease drivers and therapeutic targets.

OBJECTIVES:

We sought to identify genetic determinants of PPP and investigate whether cigarette smoking contributes to disease pathogenesis.

METHODS:

We performed a genome-wide association meta-analysis of 3 North-European cohorts (n = 1,456 PPP cases and 402,050 controls). We then used the scGWAS program to investigate the cell-type specificity of the association signals. We also undertook genetic correlation analyses to examine the similarities between PPP and other immune-mediated diseases. Finally, we applied Mendelian randomization to analyze the causal relationship between cigarette smoking and PPP.

RESULTS:

We found that PPP is not associated with the main genetic determinants of plaque psoriasis. Conversely, we identified genome-wide significant associations with the FCGR3A/FCGR3B and CCHCR1 loci. We also observed 13 suggestive (P < 5 × 10-6) susceptibility regions, including the IL4/IL13 interval. Accordingly, we demonstrated a significant genetic correlation between PPP and TH2-mediated diseases such as atopic dermatitis and ulcerative colitis. We also found that genes mapping to PPP-associated intervals were preferentially expressed in dendritic cells and often implicated in T-cell activation pathways. Finally, we undertook a Mendelian randomization analysis, which supported a causal role of cigarette smoking in PPP.

CONCLUSIONS:

The first genome-wide association study of PPP points to a pathogenic role for deregulated TH2 responses and cigarette smoking.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Células Th2 / Estudo de Associação Genômica Ampla / Fumar Cigarros Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Células Th2 / Estudo de Associação Genômica Ampla / Fumar Cigarros Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido